tv3326 has been researched along with memoquin in 1 studies
Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (memoquin) | Trials (memoquin) | Recent Studies (post-2010) (memoquin) |
---|---|---|---|---|---|
15 | 0 | 11 | 22 | 0 | 12 |
Protein | Taxonomy | tv3326 (IC50) | memoquin (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.0067 | |
Amyloid-beta precursor protein | Homo sapiens (human) | 5.93 | |
Cholinesterase | Homo sapiens (human) | 1.1808 | |
Acetylcholinesterase | Homo sapiens (human) | 0.8485 | |
Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.0016 | |
Beta-secretase 1 | Homo sapiens (human) | 0.8567 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
1 review(s) available for tv3326 and memoquin
Article | Year |
---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |